Tag: Stifel
Adyen: finishes in the red, Stifel lowers its opinion
(CercleFinance.com) – The stock ended down almost 0.6% after Stifel’s negative analysis. The analyst announced Monday that he had lowered his recommendation on Stifel shares to ‘hold’ versus ‘buy’ previously,…
Adyen: the stock falls, Stifel does not see catalysts
(CercleFinance.com) – Adyen suffered one of the biggest falls in the AEX index this Monday on the Amsterdam Stock Exchange following the lowering of Stifel’s recommendation, which drastically reduced its…
Siemens Healthineers: Stifel resumes purchase monitoring
(CercleFinance.com) – Stifel resumes monitoring of Siemens Healthineers with a ‘buy’ recommendation and a price target of 55 euros, considering in particular that the strong imaging positions of the German…
Bureau Veritas: Stifel confirms its stock advice
(CercleFinance.com) – Stifel maintains its buy rating on Bureau Veritas shares with an unchanged price target of 28 euros. The stock remains the analyst’s favorite pick in the ICT sector,…
Airbus group: Airbus’ stock market discount against Boeing is excessive, according to Stifel
(BFM Bourse) – The design office has resumed its coverage of the European aeronautics and defense group, with advice on purchase and a target price of 165 euros. The company…
CRH: Stifel confirms its advice on the stock
(CercleFinance.com) – Stifel confirms its buy rating on CRH shares, with an unchanged price target of 65 euros. Yesterday, CRH released a strong set of results and guidance, beating the…
Virbac: Why the Virbac veterinary lab finds itself downgraded by Stifel
(BFM Bourse) – The research department has lowered its advice on the value to “keep” against “buy” previously, judging that the basis of comparison for the third quarter and the…
Virbac: Stifel downgrades its recommendation
(CercleFinance.com) – Stifel downgrades from ‘buy’ to ‘keep’ its recommendation on Virbac, in view of a limited upside potential compared to its target price lowered to 293 euros (against 342…
Virbac down sharply after its degradation by Stifel
(AOF) – Virbac (-3.30% to 263.50 euros) is the red lantern of the SRD market and the SBF120 index after its degradation by Stifel. The broker went from Buy to…
Bayer: Stifel confirms his advice on the title
(CercleFinance.com) – Stifel maintains its buy rating on Bayer shares, with an unchanged price target of 68 euros. The analyst returns to the conference call of the general manager analyzing…
Intercontinental: Stifel confirms its analysis on the title
(CercleFinance.com) – Stifel maintains its rating on the Intercontinental title, with an unchanged price target of 5,700 pence. The analysts report that the 1st half results announced yesterday came out…
Elior: Stifel degrades for Sale
(AOF) – Stifel has lowered its recommendation to Hold for Sale and its price target from 3.30 euros to 1.90 euros on Elior. “Last week’s third-quarter sales release came with…